Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, Jeon J, Gazelle GS, Feuer EJ, de Koning HJ, Meza R, Kong CY, Han SS, Plevritis SK.
Toumazis I, et al. Among authors: kong cy.
JAMA Oncol. 2021 Dec 1;7(12):1833-1842. doi: 10.1001/jamaoncol.2021.4942.
JAMA Oncol. 2021.
PMID: 34673885
Free PMC article.